Miao J, Zhang Y, Su C, Zheng Q, Guo J
Mol Neurobiol. 2024; 62(3):3195-3225.
PMID: 39240280
PMC: 11790777.
DOI: 10.1007/s12035-024-04457-1.
Muhammad T, Li M, Wang J, Huang T, Zhao S, Zhao H
Sci China Life Sci. 2020; 63(6):849-865.
PMID: 32291558
DOI: 10.1007/s11427-019-1646-y.
Hehar H, Ma I, Mychasiuk R
Sci Rep. 2017; 7(1):7171.
PMID: 28769086
PMC: 5541091.
DOI: 10.1038/s41598-017-07784-7.
Chang K, Lee N, Kuo W, Hu W, Chang M, Tsai F
Acta Cardiol Sin. 2016; 30(1):56-66.
PMID: 27122769
PMC: 4804822.
Bhattacharya A, Klann E
Learn Mem. 2012; 19(9):434-43.
PMID: 22904374
PMC: 3418762.
DOI: 10.1101/lm.025007.111.
Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma.
Jang H, Kang K, Choi B, Chai G, Hong S, Ha W
World J Gastroenterol. 2008; 14(9):1394-8.
PMID: 18322954
PMC: 2693688.
DOI: 10.3748/wjg.14.1394.
M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis.
Jamieson T, Brizel D, Killian J, Oka Y, Jang H, Fu X
BMC Cancer. 2003; 3:4.
PMID: 12589712
PMC: 151601.
DOI: 10.1186/1471-2407-3-4.
Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3.
Utada Y, Haga S, Kajiwara T, Kasumi F, Sakamoto G, Nakamura Y
Jpn J Cancer Res. 2000; 91(3):293-300.
PMID: 10760688
PMC: 5926368.
DOI: 10.1111/j.1349-7006.2000.tb00944.x.
Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas.
Chappell S, Walsh T, Walker R, Shaw J
Br J Cancer. 1997; 76(12):1558-61.
PMID: 9413941
PMC: 2228213.
DOI: 10.1038/bjc.1997.596.
Translocation between chromosomes 6 and 15 (45,XX,t(6;15)(q25;q11.2)) with further evidence for lack of imprinting of the insulin-like growth factor II/mannose-6-phosphate receptor in humans.
Treacy E, Polychronakos C, Vekemans M, Eydoux P, Blaichman S, Scarpelli H
J Med Genet. 1996; 33(1):42-6.
PMID: 8825047
PMC: 1051810.
DOI: 10.1136/jmg.33.1.42.
Comparative map for mice and humans.
Nadeau J, Davisson M, Doolittle D, Grant P, Hillyard A, Kosowsky M
Mamm Genome. 1991; 1 Spec No:S461-515.
PMID: 1799811
DOI: 10.1007/BF00656504.
Mouse map of paralogous genes.
Nadeau J, Kosowsky M
Mamm Genome. 1991; 1 Spec No:S433-60.
PMID: 1799810
DOI: 10.1007/BF00656503.
Mouse chromosome 17.
Artzt K, Barlow D, Dove W, Klein J, Lyon M, Silver L
Mamm Genome. 1991; 1 Spec No:S280-300.
PMID: 1799805
DOI: 10.1007/BF00656498.
Maps of mouse chromosome 17: first report. Committee for Mouse Chromosome 17.
Mamm Genome. 1991; 1(1):5-29.
PMID: 1794045
SacI RFLP in the insulin-like growth factor 2 receptor gene (IGF2R) on human chromosome 6q.
Hauptschein R, Dalla-Favera R, Gaidano G
Nucleic Acids Res. 1991; 19(24):6974.
PMID: 1684856
PMC: 329366.
DOI: 10.1093/nar/19.24.6974.
Major histocompatibility complex, t-complex, and leukemia.
Dorak M, Burnett A
Cancer Causes Control. 1992; 3(3):273-82.
PMID: 1610974
DOI: 10.1007/BF00124261.
Mouse chromosome 17.
Silver L, Artzt K, Barlow D, Lyon M, Klein J, Snyder L
Mamm Genome. 1992; 3 Spec No:S241-60.
PMID: 1498437
DOI: 10.1007/BF00648435.
Comparative map for mice and humans.
Nadeau J, Davisson M, Doolittle D, Grant P, Hillyard A, Kosowsky M
Mamm Genome. 1992; 3(9):480-536.
PMID: 1392257
DOI: 10.1007/BF00778825.
Dinucleotide repeat polymorphism at the IGF2R locus.
Goto J, Figlewicz D, Marineau C, Khodr N, Rouleau G
Nucleic Acids Res. 1992; 20(4):923.
PMID: 1311836
PMC: 312050.
DOI: 10.1093/nar/20.4.923.